Immunogenicity of the Recombinant Zoster Vaccine in Multiple Sclerosis Patients

Conditions:   Shingles;   Zoster Intervention:   Biological: recombinant zoster vaccine Sponsor:   Prof Patrice Lalive Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials